SML2064

LBQ657

≥97% (HPLC), neprilysin inhibitor, powder

• Synonym(s): (2R,4S)-5-(Biphenyl-4-yl)-4-((3-carboxypropionyl)amino)-2-methylpentanoic acid, Desethyl sacubitril, Sacubitrilat
• Empirical Formula (Hill Notation): C₂₂H₂₅NO₅
• CAS Number: 149709-44-4
• Molecular Weight: 383.44
• NACRES: NA.77
• UNSPSC Code: 12352200
• MDL number: MFCD00921225
• Assay: ≥97% (HPLC)
• Form: powder

Properties

• Product Name: LBQ657, ≥97% (HPLC)
• assay: ≥97% (HPLC)
• form: powder
• optical activity: [α]/D -35 to -27°, c = 1 in methanol
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• shipped in: wet ice
• storage temp.: −20°C
• SMILES string: OC(CCC(N[C@H](CC1=CC=C(C2=CC=CC=C2)C=C1)C[C@H](C(O)=O)C)=O)=O
• InChI: 1S/C22H25NO5/c1-15(22(27)28)13-19(23-20(24)11-12-21(25)26)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,15,19H,11-14H2,1H3,(H,23,24)(H,25,26)(H,27,28)/t15-,19+/m1/s1
• InChI key: DOBNVUFHFMVMDB-BEFAXECRSA-N

Description

Biochem/physiol Actions

Inhibitor of neprilysin (neutral endopeptidase, NEP) formed by the action of esterases on its prodrug sacubitril (AHU377)

LBQ657 is the active metabolite of sacubitril. It is an inhibitor of the enkephalinase neprilysin (neutral endopeptidase, NEP) formed by the action of esterases on its prodrug sacubitril (AHU377), which is half of the heart failure combination drug Entresto, along with the angiotensin-receptor blocker Valsartan. LBQ657 prevents neprilysin′s degradation of atrial and brain natriuretic peptide, two blood pressure lowering peptides.

Safety Information

• Pictograms: GHS08,GHS07
• Signal Word: Danger
• Hazard Codes: H336,H372
• Precautionary Statements: P260 - P264 - P271 - P304 + P340 + P312 - P314 - P403 + P233
• Hazard Classifications: STOT RE 1 - STOT SE 3
• Target Organs: Bone,Kidney, Central nervous system
• Storage Class: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable